|
| 37778954 | The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial. | Eur Urol | 2024 |
| 36681537 | Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]. | Eur Urol | 2023 |
| 37656223 | Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. | J Med Econ | 2023 |
| 37385981 | External validation of a risk model predicting failure of salvage focal ablation for prostate cancer. | BJU Int | 2023 |
| 37014172 | Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience. | J Urol | 2023 |
| 36653670 | Landmarks in the evolution of prostate biopsy. | Nat Rev Urol | 2023 |
| 36511804 | Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial. | Radiology | 2023 |
| 35300937 | Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker. | Eur Urol Focus | 2022 |
| 35370021 | Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy. | Eur Urol | 2022 |
| 35123819 | Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. | Eur Urol | 2022 |
| 31590961 | Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer. | Eur Urol Focus | 2021 |
| 33504940 | Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study. | Prostate Cancer Prostatic Dis | 2021 |
| 33632752 | Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial. | BMJ Open | 2021 |
| 34977691 | A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer. | Eur Urol Open Sci | 2021 |
| 34407860 | Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study. | Trials | 2021 |
| 34678156 | A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. | Lancet Oncol | 2021 |
| 34794989 | Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study. | BMJ Open | 2021 |
| 33934114 | Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control. | Prostate Cancer Prostatic Dis | 2021 |
| 34318981 | Multiparametric magnetic resonance imaging - a crucial imaging tool for considering and planning prostate cancer focal therapy. | BJU Int | 2021 |
| 34139356 | PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study. | Contemp Clin Trials | 2021 |
| 33051065 | False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS. | Eur Urol | 2021 |
| 32638084 | Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. | World J Urol | 2021 |
| 32745350 | Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study. | BJU Int | 2021 |
| 31307961 | A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER. | Eur Urol Oncol | 2020 |
| 31928408 | Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound. | J Urol | 2020 |
| 33057024 | A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists. | Sci Rep | 2020 |
| 32676440 | Focal therapy, time to join the multi-disciplinary team discussion? | Transl Androl Urol | 2020 |
| 32312543 | Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study. | Eur Urol | 2020 |
| 32370911 | What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort. | Eur Urol | 2020 |
| 32253928 | An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer. | J Endourol | 2020 |
| 32314931 | Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study. | J Urol | 2020 |
| 30638633 | Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry. | Eur Urol | 2019 |
| 31537406 | Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers. | Eur Urol | 2019 |
| 30912958 | Establishing MRI-guided prostate intervention at a UK Centre. | Br J Radiol | 2019 |
| 29662167 | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. | Nat Genet | 2018 |
| 29888845 | Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer. | BJU Int | 2018 |
| 29960750 | A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. | Eur Urol | 2018 |
| 30040065 | Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. | Health Technol Assess | 2018 |
| 30264692 | Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT. | Health Technol Assess | 2018 |
| 28815981 | Positive messages for bladder cancer management in negative sentinel lymph node study. | BJU Int | 2017 |
| 28945760 | Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. | PLoS Genet | 2017 |
| 26709240 | The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. | BJU Int | 2016 |
| 24913090 | Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. | Eur J Surg Oncol | 2015 |
| 26018901 | Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 25730763 | Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 25510570 | Retroperitoneal lymph node dissection (RPLND) - open surgery's next challenger is ready to enter the ring. | BJU Int | 2015 |
| 24467630 | Evolution of the Southampton Enhanced Recovery Programme for radical cystectomy and the aggregation of marginal gains. | BJU Int | 2014 |
| 27637531 | Robot-assisted management of Zinner's syndrome: report of seminal vesicle sparing technique and review of literature. | J Robot Surg | 2014 |
| 23065704 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. | Hum Mol Genet | 2013 |
| 23535732 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. | Nat Genet | 2013 |